Artykuły w czasopismach na temat „Serious infectious diseases”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Serious infectious diseases”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Masini, Lucia, Massimo Apicella, Carmen De Luca, et al. "Fetal Central Nervous System and Infectious Diseases." Donald School Journal of Ultrasound in Obstetrics and Gynecology 11, no. 4 (2017): 314–27. http://dx.doi.org/10.5005/jp-journals-10009-1539.
Pełny tekst źródłaShanson, D. C. "Treatment of serious infections in the 1990s (contemporary issues in infectious diseases)." Journal of Hospital Infection 22, no. 4 (1992): 341. http://dx.doi.org/10.1016/0195-6701(92)90025-h.
Pełny tekst źródłaChristodoulou, Mario. "A serious virus, a serious game." Lancet Infectious Diseases 10, no. 8 (2010): 519. http://dx.doi.org/10.1016/s1473-3099(10)70154-7.
Pełny tekst źródłaSzymczyk, Halina. "Vaccination – the best method of combating serious infectious diseases." Medycyna Ogólna i Nauki o Zdrowiu 22, no. 4 (2016): 245–52. http://dx.doi.org/10.5604/20834543.1227604.
Pełny tekst źródłaMurphy, Mark, Sonya Tang Girdwood, and Marc H. Scheetz. "Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin." Journal of Hospital Medicine 15, no. 12 (2020): 740–42. http://dx.doi.org/10.12788/jhm.3507.
Pełny tekst źródłaPaszkowska, Małgorzata. "STATUTORY OBLIGATIONS OF A DOCTOR IN THE FIELD OF PREVENTION AND CONTROL OF INFECTIOUS DISEASES." Wiadomości Lekarskie 73, no. 4 (2020): 801–8. http://dx.doi.org/10.36740/wlek202004135.
Pełny tekst źródłaЕрмоленко, К. Ю., Ю. С. Александрович, К. Д. Ермоленко, К. В. Пшениснов, and А. И. Конев. "Assessment of Serious Condition and Prediction of Outcomes of Infectious Diseases in Children." Клиническая инфектология и паразитология, no. 3 (October 27, 2022): 192–203. http://dx.doi.org/10.34883/pi.2022.11.3.026.
Pełny tekst źródłaMurray, Gardner. "Australia's vital assistance to Asian nations fighting serious infectious diseases." Australian Veterinary Journal 77, no. 5 (1999): 339. http://dx.doi.org/10.1111/j.1751-0813.1999.tb10282.x.
Pełny tekst źródłaMaleyev, V. V. "Selected aspects of infectious disease evolution in the modern world." Kuban Scientific Medical Bulletin 27, no. 4 (2020): 18–26. http://dx.doi.org/10.25207/1608-6228-2020-27-4-18-26.
Pełny tekst źródłaHedayati, Manouchehr Ahmadi, and Nasrin Bahmani. "Most important bacterial and parasitic zoonotic diseases in Iran." Reviews and Research in Medical Microbiology 34, no. 1 (2022): 12–21. http://dx.doi.org/10.1097/mrm.0000000000000320.
Pełny tekst źródłaJayesh, Vyas, Singh Devendra, Kumar Kuldeep Shantanu, and Nirwan Aarti. "Lumpy skin disease: A worldwide serious concern." Science World a monthly e magazine 2, no. 2 (2022): 110–13. https://doi.org/10.5281/zenodo.6137060.
Pełny tekst źródłaMurray, Thomas S., M. Elizabeth Groth, Carol Weitzman, and Michael Cappello. "Epidemiology and Management of Infectious Diseases in International Adoptees." Clinical Microbiology Reviews 18, no. 3 (2005): 510–20. http://dx.doi.org/10.1128/cmr.18.3.510-520.2005.
Pełny tekst źródłaSmith, Raymond P. "Serious infections in the elderly." Clinical Microbiology Newsletter 11, no. 23 (1989): 177–81. http://dx.doi.org/10.1016/0196-4399(89)90029-9.
Pełny tekst źródłaAnokhin, V. A. "Modern principles of clinical and laboratory diagnosis of herpes infections." Kazan medical journal 80, no. 2 (1999): 127–29. http://dx.doi.org/10.17816/kazmj66466.
Pełny tekst źródłaRia Rai, Arshia Sharma, and Sahil Negi. "Emerging Infectious Diseases: A Persistent Threat to the Community." International Healthcare Research Journal 7, no. 12 (2024): RV17—RV20. http://dx.doi.org/10.26440/ihrj/0712.03626.
Pełny tekst źródłaRiley, Thomas V., and Christine F. Carson. "Non-antibiotic therapies for infectious diseases." Communicable Diseases Intelligence 27 (May 30, 2003): S144—S147. https://doi.org/10.33321/cdi.2003.27.38.
Pełny tekst źródłaIwata, Kentaro, Goh Ohji, Hideaki Oka, et al. "Communicable Diseases After the Disasters: with the Special Reference to the Great East Japan Earthquake." Journal of Disaster Research 7, no. 6 (2012): 746–53. http://dx.doi.org/10.20965/jdr.2012.p0746.
Pełny tekst źródłaXu, Hao-Ming, Wen-Min Xu, and Long Zhang. "Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases." International Journal of Clinical Practice 2022 (October 3, 2022): 1–22. http://dx.doi.org/10.1155/2022/4913146.
Pełny tekst źródłaVukadinov, Jovan, Sinisa Sevic, Grozdana Canak, Nadezda Madle-Samardzija, Vesna Turkulov, and Radoslava Doder. "Infections and the elderly." Medical review 56, no. 5-6 (2003): 243–46. http://dx.doi.org/10.2298/mpns0306243v.
Pełny tekst źródłaOKA, SHIN'ICHI. "Infectious diseases '98. II. Advances in treatments. 3. Treatments for serious and intractable infectious diseases and their advances. 1) HIV infectious disease." Nihon Naika Gakkai Zasshi 87, no. 11 (1998): 2240–44. http://dx.doi.org/10.2169/naika.87.2240.
Pełny tekst źródłaLatkovic, Marina. "Postexposition prophylaxis for hepatotropic viruses (HBV and HCV) and human immunodeficiency virus (HIV)." Serbian Dental Journal 57, no. 4 (2010): 212–19. http://dx.doi.org/10.2298/sgs1004212l.
Pełny tekst źródłaFeng, Jia, Ahmed Waqas, Zhihan Zhu, and Lukui Chen. "Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19)." Journal of Biomedical Nanotechnology 16, no. 4 (2020): 399–418. http://dx.doi.org/10.1166/jbn.2020.2910.
Pełny tekst źródłaFUNADA, HISASHI. "Infectious diseases '98. II. Advances in treatments. 3. Treatments for serious and intractable infectious diseases and their advances. 3) Septicemia." Nihon Naika Gakkai Zasshi 87, no. 11 (1998): 2250–56. http://dx.doi.org/10.2169/naika.87.2250.
Pełny tekst źródłaAhmadi, Khadijeh, Zahra Gharibi, Parivash Davoodian, Hamed Gouklani, Mehdi Hassaniazad, and Nahid Ahmadi. "The Effect of Smoking on the Increase of Infectious Diseases." Tobacco and Health 1, no. 2 (2022): 100–106. http://dx.doi.org/10.34172/thj.2022.15.
Pełny tekst źródłaJohnston, BL, and JM Conly. "Tumour Necrosis Factor Inhibitors and Infection: What Is there to Know for Infectious Diseases Physicians?" Canadian Journal of Infectious Diseases and Medical Microbiology 17, no. 4 (2006): 209–12. http://dx.doi.org/10.1155/2006/385789.
Pełny tekst źródłaJabeen, K., J. Farooqi, S. Mirza, D. Denning, and A. Zafar. "Serious fungal infections in Pakistan." European Journal of Clinical Microbiology & Infectious Diseases 36, no. 6 (2017): 949–56. http://dx.doi.org/10.1007/s10096-017-2919-6.
Pełny tekst źródłaHuh, K., Y. E. Ha, D. W. Denning, and K. R. Peck. "Serious fungal infections in Korea." European Journal of Clinical Microbiology & Infectious Diseases 36, no. 6 (2017): 957–63. http://dx.doi.org/10.1007/s10096-017-2923-x.
Pełny tekst źródłaBustamante, B., D. W. Denning, and P. E. Campos. "Serious fungal infections in Peru." European Journal of Clinical Microbiology & Infectious Diseases 36, no. 6 (2017): 943–48. http://dx.doi.org/10.1007/s10096-017-2924-9.
Pełny tekst źródłaChayakulkeeree, M., and D. W. Denning. "Serious fungal infections in Thailand." European Journal of Clinical Microbiology & Infectious Diseases 36, no. 6 (2017): 931–35. http://dx.doi.org/10.1007/s10096-017-2927-6.
Pełny tekst źródłaSabino, R., C. Verissímo, J. Brandão, et al. "Serious fungal infections in Portugal." European Journal of Clinical Microbiology & Infectious Diseases 36, no. 7 (2017): 1345–52. http://dx.doi.org/10.1007/s10096-017-2930-y.
Pełny tekst źródłaLiu, Dan, Wulantuya, Hongxia Fan, et al. "Co-infection of tick-borne bacterial pathogens in ticks in Inner Mongolia, China." PLOS Neglected Tropical Diseases 17, no. 3 (2023): e0011121. http://dx.doi.org/10.1371/journal.pntd.0011121.
Pełny tekst źródłaFauci, Anthony S., Nancy A. Touchette, and Gregory K. Folkers. "Emerging infectious diseases: A 10-year perspective from the National Institute of Allergy and Infectious Diseases." International Journal of Risk & Safety in Medicine 17, no. 3-4 (2005): 157–67. https://doi.org/10.3233/jrs-2005-351.
Pełny tekst źródłaIbragimov, S.J., D.O Razzoqberganova, Q.Y. Yoqubov, and O.N. Atadjanova. "EMERGENCIES IN INFECTIOUS DISEASES: EPIDEMIOLOGICAL, MEDICAL AND SOCIAL ASPECTS." Multidisciplinary Journal of Science and Technology 5, no. 3 (2025): 63–67. https://doi.org/10.5281/zenodo.14978063.
Pełny tekst źródłaHoogkamp-Korstanje, J. A. A., K. J. van Erpecum, and H. van Kamp. "Ceftazidime in serious hospital-acquired infections." Journal of Antimicrobial Chemotherapy 15, no. 6 (1985): 743–49. http://dx.doi.org/10.1093/jac/15.6.743.
Pełny tekst źródłaAlasil, Saad M., and Khairul A. Abdullah. "An Epidemiological Review on Emerging and Re-Emerging Parasitic Infectious Diseases in Malaysia." Open Microbiology Journal 13, no. 1 (2019): 112–20. http://dx.doi.org/10.2174/1874285801913010112.
Pełny tekst źródłaRehm, Susan J., and John G. Bartlett. "Challenges in the Management of Serious Infections." Clinical Infectious Diseases 42, Supplement_2 (2006): S63—S64. http://dx.doi.org/10.1086/499403.
Pełny tekst źródłaNielsen, Donald M., James R. Katz, Ronald D. AhLoy, Ralph S. Hansen, and Richard D. Meyer. "Imipenem/Cilastatin Therapy for Serious Bacterial Infections." Clinical Infectious Diseases 7, Supplement_3 (1985): S506—S512. http://dx.doi.org/10.1093/clinids/7.supplement_3.s506.
Pełny tekst źródłaWebster, Alison, and Harold Gaya. "Quinolones in the Treatment of Serious Infections." Clinical Infectious Diseases 10, Supplement_1 (1988): S225—S233. http://dx.doi.org/10.1093/clinids/10.supplement_1.s225.
Pełny tekst źródłaWallace, Madison L., and Ken S. Rosenthal. "Vaccine protection of the mother, the fetus, neonates and infants." AIMS Allergy and Immunology 8, no. 2 (2024): 124–45. http://dx.doi.org/10.3934/allergy.2024007.
Pełny tekst źródłaChow, Franklin Wang-Ngai. "Genomics: Infectious Disease and Host–Pathogen Interaction." International Journal of Molecular Sciences 24, no. 2 (2023): 1748. http://dx.doi.org/10.3390/ijms24021748.
Pełny tekst źródłaZENIYA, MIKIO. "Infectious diseases '98. II. Advances in treatments. 3. Treatments for serious and intractable infectious diseases and their advances. 2) Viral hepatitis." Nihon Naika Gakkai Zasshi 87, no. 11 (1998): 2245–49. http://dx.doi.org/10.2169/naika.87.2245.
Pełny tekst źródłaFetrat, Safiullah. "Impact of Environmental Pollution on Infectious Disease Incidence: Challenges and Preventive Solutions: A Review Article." Afghanistan Journal of Infectious Diseases 3, no. 1 (2025): 1–9. https://doi.org/10.60141/ajid.71.
Pełny tekst źródłaRatnadass, Alain, and Mathilde Sester. "Crop protection practices and risks associated with human fungal infectious diseases: a One Health perspective." Cahiers Agricultures 32 (2023): 7. http://dx.doi.org/10.1051/cagri/2022036.
Pełny tekst źródłaKershaw, Colleen, Jon D. Lurie, Charles Brackett, et al. "Improving care for individuals with serious infections who inject drugs." Therapeutic Advances in Infectious Disease 9 (January 2022): 204993612211424. http://dx.doi.org/10.1177/20499361221142476.
Pełny tekst źródłaShi, ZhengLi. "Emerging infectious diseases associated with bat viruses." Science China Life Sciences 56, no. 8 (2013): 678–82. https://doi.org/10.5281/zenodo.13530144.
Pełny tekst źródłaShi, ZhengLi. "Emerging infectious diseases associated with bat viruses." Science China Life Sciences 56, no. 8 (2013): 678–82. https://doi.org/10.5281/zenodo.13530144.
Pełny tekst źródłaAJISAWA, ATSUSHI. "Internal medical disease. Practice of emergency care. From mild diseases to serious diseases VIII. Infectious diseases and others. Septicemia." Nihon Naika Gakkai Zasshi 88, no. 12 (1999): 2421–27. http://dx.doi.org/10.2169/naika.88.2421.
Pełny tekst źródłaPau, Alice K. "Antiretroviral therapy-associated serious and life-threatening toxicities." Current Infectious Disease Reports 5, no. 5 (2003): 429–38. http://dx.doi.org/10.1007/s11908-003-0023-9.
Pełny tekst źródłaRybak, Michael J., Jennifer Le, Thomas P. Lodise, et al. "Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists." Clinical Infectious Diseases 71, no. 6 (2020): 1361–64. http://dx.doi.org/10.1093/cid/ciaa303.
Pełny tekst źródłaRathor, H. R. "The role of vectors in emerging and re-emerging diseases in the Eastern Mediterranean Region." Eastern Mediterranean Health Journal 2, no. 1 (2021): 61–67. http://dx.doi.org/10.26719/1996.2.1.61.
Pełny tekst źródła